These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 12972087

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Development and validation of a HPLC method for 4,7-phenanthroline-5,6-dione I and identification of its major impurity by HPLC-MS-APCI.
    Shabir GA, Forrow NJ.
    J Chromatogr Sci; 2005 Apr; 43(4):207-12. PubMed ID: 15975237
    [Abstract] [Full Text] [Related]

  • 3. Reversed-phase liquid chromatography analysis of imatinib mesylate and impurity product in Glivec capsules.
    Ivanovic D, Medenica M, Jancic B, Malenovic A.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Feb 05; 800(1-2):253-8. PubMed ID: 14698262
    [Abstract] [Full Text] [Related]

  • 4. LC determination of glimepiride and its related impurities.
    Khan MA, Sinha S, Vartak S, Bhartiya A, Kumar S.
    J Pharm Biomed Anal; 2005 Oct 04; 39(5):928-43. PubMed ID: 16040224
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development and validation of a method for the purity determination of (3beta,20R)-4,4-dimethylcholesta-8,14,24-trien-3-ol(FF-MAS) in pharmaceutical products containing recombinant human albumin.
    Jamali B, Andersen SG, Brødholt H, Wendel L, Bødstrup V.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct 25; 810(2):251-7. PubMed ID: 15380722
    [Abstract] [Full Text] [Related]

  • 9. Determination of cetirizine dihydrochloride, related impurities and preservatives in oral solution and tablet dosage forms using HPLC.
    Jaber AM, Al Sherife HA, Al Omari MM, Badwan AA.
    J Pharm Biomed Anal; 2004 Oct 29; 36(2):341-50. PubMed ID: 15496327
    [Abstract] [Full Text] [Related]

  • 10. Development and validation of a HPLC-UV method for the determination in didanosine tablets.
    de Oliveira AM, Löwen TC, Cabral LM, dos Santos EM, Rodrigues CR, Castro HC, dos Santos TC.
    J Pharm Biomed Anal; 2005 Jul 15; 38(4):751-6. PubMed ID: 15967304
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development and validation of a new HPLC-UV method for the simultaneous determination of triclabendazole and ivermectin B1a in a pharmaceutical formulation.
    Shurbaji M, Abu Al Rub MH, Saket MM, Qaisi AM, Salim ML, Abu-Nameh ES.
    J AOAC Int; 2010 Jul 15; 93(6):1868-73. PubMed ID: 21313814
    [Abstract] [Full Text] [Related]

  • 14. Experimental design in reversed-phase high-performance liquid chromatographic analysis of imatinib mesylate and its impurity.
    Medenica M, Jancic B, Ivanovic D, Malenovic A.
    J Chromatogr A; 2004 Mar 26; 1031(1-2):243-8. PubMed ID: 15058589
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Identification of the impurities in o-chlorophenyl cyclopentyl ketone samples by high performance liquid chromatography-hybrid ion trap/time-of-flight mass spectrometry and preparation of o-chlorophenyl cyclopentyl ketone standard].
    Ma X, Jin L, Li Y, Zheng H, Wei Y.
    Se Pu; 2018 Mar 08; 36(3):268-277. PubMed ID: 30136505
    [Abstract] [Full Text] [Related]

  • 18. Development of a purity control strategy for pemetrexed disodium and validation of associated analytical methodology.
    Warner A, Piraner I, Weimer H, White K.
    J Pharm Biomed Anal; 2015 Feb 08; 105():46-54. PubMed ID: 25527981
    [Abstract] [Full Text] [Related]

  • 19. A novel stability-indicating UPLC method development and validation for the determination of seven impurities in various diclofenac pharmaceutical dosage forms.
    Azougagh M, Elkarbane M, Bakhous K, Issmaili S, Skalli A, Iben Moussad S, Benaji B.
    Ann Pharm Fr; 2016 Sep 08; 74(5):358-69. PubMed ID: 27475309
    [Abstract] [Full Text] [Related]

  • 20. Normal phase and reverse phase HPLC-UV-MS analysis of process impurities for rapamycin analog ABT-578: application to active pharmaceutical ingredient process development.
    Chen Y, Brill GM, Benz NJ, Leanna MR, Dhaon MK, Rasmussen M, Zhou CC, Bruzek JA, Bellettini JR.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct 15; 858(1-2):106-17. PubMed ID: 17826364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.